✦ LIBER ✦

Irbesartan cost effective for treatment of kidney disease in type 2 DM

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Towards Cost-effective Strategies for Tr

✍ Hirotaka Komaba; Kensuke Moriwaki; Isao Kamae; Masafumi Fukagawa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PC VI THE COST-EFFECTIVENESS OF IRBESART

✍ WC Yang; L Annemans; YY Ng; SJ Hwang 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PCV79 THE COST-EFFECTIVENESS OF IRBESART

✍ S Hu; W Chen; L Annemans 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

An Asian Regional Analysis of Cost-Effec

✍ Lieven Annemans; Nadia Demarteau; Shanlian Hu; Tae-Jin Lee; Zaher Morad; Thanom 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB

PCV32 COST-EFFECTIVENESS OF IRBESARTAN I

✍ H Hernandez; L Lepe; A Gonzalez; A Lemus 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PDB24 A COST-EFFECTIVENESS ANALYSIS OF I

✍ TJ Lee; DS Han; HS Sohn 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB